Is AB4AD (Antibodies for Alzheimer's Disease) (ab4ad) a Scam?

AB4AD (Antibodies for Alzheimer's Disease) low risk. ZARQ Trust Rating: NR. 0 risk flags detected. Trust Score: N/A/100. Vitality: 37.5/100. Last analyzed March 2026.

LOW RISK

0 minor risk flag. Established project.

0
Risk Flags
NR
Rating
N/A
Trust Score
37.5
Vitality

Legitimacy Indicators

SignalStatusAssessment
Structural Risk Flags0 detectedClean
Vitality Score37.5/100Low activity
Trust RatingNRUnrated
Risk LevelN/A
Price Data AvailableYesActively traded

Common Scam Red Flags

ZARQ checks for: concentrated token ownership, locked vs. unlocked liquidity, contract audit status, anonymous teams, unrealistic yield promises, and sudden liquidity changes. AB4AD (Antibodies for Alzheimer's Disease) currently shows 0 of these flags.

Frequently Asked Questions

Is AB4AD (Antibodies for Alzheimer's Disease) a scam?
AB4AD (Antibodies for Alzheimer's Disease) shows 0 structural risk flags. Verdict: low risk. 0 minor risk flag. Established project.
Is AB4AD (Antibodies for Alzheimer's Disease) legit?
ZARQ Trust Rating: NR. Vitality: 37.5/100. Limited activity signals detected.
Can I trust AB4AD (Antibodies for Alzheimer's Disease)?
Trust score: N/A/100. 0 structural risk flags detected. Always verify independently before investing.
Is AB4AD (Antibodies for Alzheimer's Disease) a rug pull?
Structural weakness score: 0. No rug pull indicators detected.
How safe is AB4AD (Antibodies for Alzheimer's Disease)?
ZARQ rates AB4AD (Antibodies for Alzheimer's Disease) at NR. Crash probability: N/A%. Risk level: N/A. This is a quantitative assessment, not investment advice.

API Access

curl -s zarq.ai/v1/crypto/check/ab4ad-antibodies-for-alzheimer-s-disease | jq .risk_flags
All Tokens Crash Watch Vitality Yield Risk Contagion Methodology Track Record Scan Portfolio Full Analysis Dead? Scam? Crash?

ZARQ ratings are quantitative risk assessments based on public blockchain data, not investment advice. Past performance does not predict future results. Always do your own research.